GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,796,000 | +1.4% | 41,247 | +1.4% | 0.03% | +17.2% |
Q1 2022 | $1,772,000 | -3.2% | 40,666 | -2.0% | 0.03% | +3.6% |
Q4 2021 | $1,830,000 | +16.1% | 41,482 | +0.5% | 0.03% | +3.7% |
Q3 2021 | $1,576,000 | -56.1% | 41,262 | -59.0% | 0.03% | -58.5% |
Q1 2021 | $3,590,000 | -2.9% | 100,589 | +0.1% | 0.06% | -8.5% |
Q4 2020 | $3,699,000 | +0.4% | 100,525 | +2.7% | 0.07% | -12.3% |
Q3 2020 | $3,685,000 | -1.7% | 97,905 | +6.6% | 0.08% | -8.0% |
Q2 2020 | $3,747,000 | +33.1% | 91,859 | +23.6% | 0.09% | +8.6% |
Q1 2020 | $2,816,000 | -6.3% | 74,314 | +16.2% | 0.08% | +19.1% |
Q4 2019 | $3,005,000 | +35.6% | 63,959 | +23.2% | 0.07% | +28.3% |
Q3 2019 | $2,216,000 | +40.3% | 51,912 | +31.5% | 0.05% | +39.5% |
Q2 2019 | $1,579,000 | -11.2% | 39,467 | -7.3% | 0.04% | -11.6% |
Q1 2019 | $1,779,000 | +12.5% | 42,574 | +2.9% | 0.04% | -4.4% |
Q4 2018 | $1,581,000 | -1.1% | 41,369 | +3.9% | 0.04% | +12.5% |
Q3 2018 | $1,599,000 | -5.7% | 39,804 | -5.4% | 0.04% | -13.0% |
Q2 2018 | $1,696,000 | -0.9% | 42,082 | -3.9% | 0.05% | -6.1% |
Q1 2018 | $1,711,000 | -25.2% | 43,794 | -32.1% | 0.05% | -22.2% |
Q4 2017 | $2,287,000 | -39.2% | 64,498 | -30.4% | 0.06% | -42.2% |
Q3 2017 | $3,762,000 | +4.6% | 92,643 | +11.1% | 0.11% | -3.5% |
Q2 2017 | $3,595,000 | +10.2% | 83,358 | +7.7% | 0.11% | +10.8% |
Q1 2017 | $3,263,000 | +12.8% | 77,396 | +3.0% | 0.10% | +7.4% |
Q4 2016 | $2,894,000 | -20.9% | 75,143 | -11.4% | 0.10% | -21.5% |
Q3 2016 | $3,660,000 | -2.0% | 84,858 | -1.5% | 0.12% | -8.3% |
Q2 2016 | $3,734,000 | +2.5% | 86,153 | -4.1% | 0.13% | 0.0% |
Q1 2016 | $3,642,000 | +2.2% | 89,807 | +1.7% | 0.13% | +2.3% |
Q4 2015 | $3,564,000 | +7.1% | 88,337 | +2.1% | 0.13% | +3.2% |
Q3 2015 | $3,327,000 | -7.7% | 86,507 | -0.1% | 0.12% | +2.5% |
Q2 2015 | $3,605,000 | -7.0% | 86,551 | +3.0% | 0.12% | -6.2% |
Q1 2015 | $3,876,000 | +30.0% | 83,997 | +20.4% | 0.13% | +26.2% |
Q4 2014 | $2,981,000 | -12.8% | 69,756 | -6.2% | 0.10% | -9.6% |
Q3 2014 | $3,419,000 | -5.4% | 74,361 | +10.0% | 0.11% | -1.7% |
Q2 2014 | $3,616,000 | +14.5% | 67,615 | +14.4% | 0.12% | +10.5% |
Q1 2014 | $3,157,000 | +0.9% | 59,099 | +0.9% | 0.10% | 0.0% |
Q4 2013 | $3,128,000 | +13.2% | 58,600 | +6.4% | 0.10% | +5.0% |
Q3 2013 | $2,763,000 | -0.9% | 55,076 | -1.3% | 0.10% | -4.8% |
Q2 2013 | $2,788,000 | – | 55,811 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |